Dong-E-E-Jiao Co Ltd
SZSE:000423
Intrinsic Value
Dong-E-E-Jiao Co., Ltd. engages in the research and development, manufacturing and sale of proprietary Chinese medicine, health care products, and biological drugs. [ Read More ]
The intrinsic value of one Dong-E-E-Jiao Co Ltd stock under the Base Case scenario is 63.37 CNY. Compared to the current market price of 66.5 CNY, Dong-E-E-Jiao Co Ltd is Overvalued by 5%.
Valuation Backtest
Dong-E-E-Jiao Co Ltd
Run backtest to discover the historical profit from buying and selling Dong-E-E-Jiao Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Dong-E-E-Jiao Co Ltd
Current Assets | 10.5B |
Cash & Short-Term Investments | 8.3B |
Receivables | 1.2B |
Other Current Assets | 1.1B |
Non-Current Assets | 2.8B |
Long-Term Investments | 151.6m |
PP&E | 1.9B |
Intangibles | 323.4m |
Other Non-Current Assets | 388.1m |
Current Liabilities | 2.4B |
Accounts Payable | 275.1m |
Accrued Liabilities | 1B |
Short-Term Debt | 2.1m |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 180.5m |
Long-Term Debt | 31m |
Other Non-Current Liabilities | 149.5m |
Earnings Waterfall
Dong-E-E-Jiao Co Ltd
Revenue
|
4.7B
CNY
|
Cost of Revenue
|
-1.4B
CNY
|
Gross Profit
|
3.3B
CNY
|
Operating Expenses
|
-2.1B
CNY
|
Operating Income
|
1.3B
CNY
|
Other Expenses
|
-103m
CNY
|
Net Income
|
1.2B
CNY
|
Free Cash Flow Analysis
Dong-E-E-Jiao Co Ltd
Profitability Score
Profitability Due Diligence
Dong-E-E-Jiao Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
Dong-E-E-Jiao Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dong-E-E-Jiao Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Dong-E-E-Jiao Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dong-E-E-Jiao Co Ltd
According to Wall Street analysts, the average 1-year price target for Dong-E-E-Jiao Co Ltd is 68.28 CNY with a low forecast of 58.58 CNY and a high forecast of 82.1 CNY.
Shareholder Return
Price
Dong-E-E-Jiao Co Ltd
Average Annual Return | -1.03% |
Standard Deviation of Annual Returns | 21.59% |
Max Drawdown | -47% |
Market Capitalization | 42.8B CNY |
Shares Outstanding | 643 976 824 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dong-E-E-Jiao Co., Ltd. engages in the research and development, manufacturing and sale of proprietary Chinese medicine, health care products, and biological drugs. The company is headquartered in Liaocheng, Shandong and currently employs 4,180 full-time employees. The firm distributes its Ejiao and Ejiao series products under the brand name of Dong-E E-Jiao. The firm is also involved in the production and sale of medical instrument and pharmaceutical excipients, as well as pharmaceutical trading business. The firm operates its business in domestic market, with East China and South China as its main markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Dong-E-E-Jiao Co Ltd stock under the Base Case scenario is 63.37 CNY.
Compared to the current market price of 66.5 CNY, Dong-E-E-Jiao Co Ltd is Overvalued by 5%.